Clinical Trial Update: Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of perifosine in locally advanced, unresectable, or metastatic pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Perifosine (perifosine)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED